Healthcare


 ASX Biotech Stocks: Big Rewards, Bigger Risks

ASX Biotech Stocks: Big Rewards, Bigger Risks

May 26, 2026 04:12 PM AEST| By Sam

Biotechnology investments offer the highest potential returns in healthcare alongside the highest failure rates, demanding specialised evaluation approaches from Australian investors.

 PainChek (ASX:PCK) Appoints Lilian Bianchi as Director Amid Digital Health Expansion

PainChek (ASX:PCK) Appoints Lilian Bianchi as Director Amid Digital Health Expansion

May 26, 2026 04:10 PM AEST| By Sam

Highlights,• PainChek Ltd (ASX:PCK) appointed Lilian Bianchi as Director effective 25 May 2026.,• Appendix 3X filing disclosed nil initial holdings in PCK securities.,• PCK shares remained flat at AUD 0.15 following the announcement.,• The update is...

 Why Healthcare Stocks Can Surprise ASX Investors

Why Healthcare Stocks Can Surprise ASX Investors

May 26, 2026 04:09 PM AEST| By Sam

Healthcare investments face regulatory, innovation, pricing and operational risks that require diversification, long-term positioning and ongoing monitoring across evolving healthcare markets.

 Why Healthcare Stocks Keep Drawing Market Attention

Why Healthcare Stocks Keep Drawing Market Attention

May 26, 2026 04:06 PM AEST| By Sam

Healthcare stocks continue attracting market attention through demographic growth, biotechnology innovation, essential demand and expanding global healthcare services, making the sector one of the most influential parts of the Australian market.

 Oil Shock Rattles ASX 200 Today as Market Mood Turns Fragile

Oil Shock Rattles ASX 200 Today as Market Mood Turns Fragile

May 26, 2026 02:09 PM AEST| By Sam

Australian shares weakened as oil price volatility and geopolitical tensions pressured market sentiment, with property and financial stocks dragging lower while selected healthcare and retail companies managed to outperform.

 Healthcare Giant Surges After Strong FY26 Earnings Beat

Healthcare Giant Surges After Strong FY26 Earnings Beat

May 26, 2026 11:15 AM AEST| By Sam

Fisher & Paykel Healthcare surged after delivering strong FY26 earnings growth, improving margins, and continued momentum across respiratory care and sleep therapy markets.

 Why This Healthcare Giant Is Surging On FY26 Results

Why This Healthcare Giant Is Surging On FY26 Results

May 26, 2026 11:09 AM AEST| By Sam

Fisher & Paykel Healthcare shares surged after strong FY26 earnings, improving margins, and continued growth across respiratory care and sleep therapy markets.

 Why Ryman Healthcare’s Turnaround Is Starting to Look Real

Why Ryman Healthcare’s Turnaround Is Starting to Look Real

May 26, 2026 10:03 AM AEST| By Sam

Ryman Healthcare has returned to focus as stronger free cash flow, improving aged care profitability, and balance sheet recovery strengthen confidence in the company’s long-term operational turnaround.

 CSL Share Price Outlook: Key Metrics Shaping Investor Focus

CSL Share Price Outlook: Key Metrics Shaping Investor Focus

May 25, 2026 03:41 PM AEST| By Sam

Explore how CSL’s financial performance, healthcare leadership, and global operations continue shaping market attention across the Australian share market and major healthcare indices.

 UBS Sector Shake-Up Leaves Australian Shares at a Crossroads

UBS Sector Shake-Up Leaves Australian Shares at a Crossroads

May 25, 2026 02:12 PM AEST| By Sam

Australia’s sharemarket is witnessing a major sector rotation as mining and healthcare gain momentum while banks, property, and consumer-linked sectors face growing economic pressure.

 Why This Aussie AI Healthcare Stock Is Expanding Fast

Why This Aussie AI Healthcare Stock Is Expanding Fast

May 25, 2026 02:09 PM AEST| By Sam

IMEXHS expanded its AI radiology technology deployment into Mexico, reflecting growing international demand for digital healthcare infrastructure and artificial intelligence-powered medical imaging solutions.

 Could 4DMedical’s Imaging Push Change Respiratory Care?

Could 4DMedical’s Imaging Push Change Respiratory Care?

May 25, 2026 02:06 PM AEST| By Sam

4DMedical’s CT:VQ platform is gaining visibility as respiratory imaging adoption discussions expand across hospitals, healthcare systems, and diagnostic markets, placing greater focus on clinical integration, regulatory progress, and healthcare innov...

 ASX 200 Stocks Face Fresh Market Pressure

ASX 200 Stocks Face Fresh Market Pressure

May 25, 2026 01:58 PM AEST| By Sam

Australian equities remained volatile as several major companies across healthcare, mining and retail sectors faced weaker outlooks, operational uncertainty and cautious sentiment amid changing economic conditions.

 CSL Limited (ASX:CSL) Operations Within the ASX 20

CSL Limited (ASX:CSL) Operations Within the ASX 20

May 25, 2026 01:47 PM AEST| By Sam

CSL Limited operates as a global biotherapeutics company across plasma-derived therapies, vaccines, and selected adjacent categories. As a constituent of the ASX 20 and the ASX 200, CSL maintains operational footprints across multiple international j...

 Why This ASX Healthcare Stock Is Suddenly Drawing Fresh Attention

Why This ASX Healthcare Stock Is Suddenly Drawing Fresh Attention

May 25, 2026 11:15 AM AEST| By Sam

Vitrafy Life Sciences gained fresh market attention after positive Phase II cryopreservation study results strengthened interest in its no-wash platelet preservation technology.

 Pacific Edge (ASX:PEB) Medicare Win Sparks Fresh Buzz

Pacific Edge (ASX:PEB) Medicare Win Sparks Fresh Buzz

May 25, 2026 10:58 AM AEST| By Sam

Pacific Edge gained renewed attention after a significant Medicare-related breakthrough strengthened discussion around its diagnostics expansion strategy and the growing role of precision medicine in global healthcare systems.

 ASX 200 Giant CSL Faces Fresh Growth Spotlight

ASX 200 Giant CSL Faces Fresh Growth Spotlight

May 25, 2026 10:40 AM AEST| By Sam

CSL continues attracting market attention as global healthcare demand, biotechnology innovation, and plasma therapy trends reinforce its position as one of Australia’s leading healthcare companies.

 Alcidion (ASX:ALC) Lands UK Deal That Turned Heads

Alcidion (ASX:ALC) Lands UK Deal That Turned Heads

May 25, 2026 10:33 AM AEST| By Sam

Alcidion strengthened its UK healthcare presence with a fresh hospital contract, highlighting growing global demand for digital clinical systems and renewed interest in Australian healthcare technology companies.

 Imugene Advances Cancer Research With Azer-cel Progress

Imugene Advances Cancer Research With Azer-cel Progress

May 22, 2026 04:21 PM AEST| By Sam

Imugene strengthens its position in cancer research after releasing encouraging azer-cel clinical trial findings for advanced blood cancer patients in the evolving immunotherapy landscape.

 Why ASX Healthcare Stocks Are Back in Focus

Why ASX Healthcare Stocks Are Back in Focus

May 22, 2026 03:53 PM AEST| By Sam

ASX healthcare shares regain attention as emerging companies advance innovation in kidney disease, cancer care, sleep health, imaging technology and gut health across global markets.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.